Caprelsa Drug Interactions: 328 Major, 312 Moderate
Caprelsa (Vandetanib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Caprelsa. Always confirm against the full prescribing information.
100 interactions
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Vandetanib.
Level 2 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Vandetanib.
Level 2 evidence
Albendazole
The metabolism of Vandetanib can be decreased when combined with Albendazole.
Level 2 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Vandetanib.
Level 2 evidence
Alfuzosin
The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Vandetanib.
Level 2 evidence
Allopurinol
Vandetanib may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Level 2 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Vandetanib.
Level 1 evidence
Amantadine
The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vandetanib.
Level 2 evidence
Ambrisentan
The serum concentration of Ambrisentan can be increased when it is combined with Vandetanib.
Level 2 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Vandetanib.
Level 2 evidence
Amoxapine
The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Vandetanib.
Level 2 evidence
Apalutamide
The serum concentration of Vandetanib can be decreased when it is combined with Apalutamide.
Level 1 evidence
Enter your NPI to unlock 50 major interactions for Caprelsa
Caprelsa (Vandetanib) has 671 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Caprelsa (Vandetanib) has 328 major, 312 moderate, and 31 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Caprelsa. Always confirm against the full prescribing information.